Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:afatinib
|
| gptkbp:administeredBy |
oral
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
L01XE13
|
| gptkbp:brand |
gptkb:Gilotrif
gptkb:Giotrif |
| gptkbp:CASNumber |
850140-72-6
|
| gptkbp:chemicalFormula |
C24H25ClFN5O3
|
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| https://www.w3.org/2000/01/rdf-schema#label |
Giotrif
|
| gptkbp:indication |
gptkb:EGFR_mutation-positive_NSCLC
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
EGFR inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
rash stomatitis paronychia |
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
|
| gptkbp:bfsParent |
gptkb:afatinib
gptkb:Afatinib |
| gptkbp:bfsLayer |
7
|